News

Stanford Medicine announces results of unprecedented Apple Heart Study

Published on: 20/03/2019

Stanford Medicine announces results of unprecedented Apple Heart Study

Stanford Medicine today reported results of the Apple Heart Study, the largest study ever of its kind, which enrolled over 400,000 participants from all 50 states in a span of only eight months. Apple and Stanford created the study to evaluate Apple Watch’s irregular rhythm notification, which occasionally checks the heart’s rhythm in the background and sends a notification if an irregular heart rhythm appears to be suggestive of atrial fibrillation (AFib). As part of the study, if an irregular heart rhythm was identified, participants received a notification on their Apple Watch and iPhone, a telehealth consultation with a doctor and an electrocardiogram (ECG) patch for additional monitoring.

“We are proud to work with Stanford Medicine as they conduct this important research and look forward to learning more about the impact of Apple Watch alongside the medical community,” said Jeff Williams, Apple’s COO. “We hope consumers will continue to gain useful and actionable information about their heart health through Apple Watch.”

Stanford Medicine researchers presented their findings today at the American College of Cardiology’s 68th Annual Scientific Session and Expo. Study results showed 0.5 percent of the over 400,000 participants received an irregular heart rhythm notification, illustrating the feature’s ability to give a user important health information without creating unnecessary burden to their doctor’s schedule. Many participants sought medical advice following their irregular rhythm notification, using the information to have more meaningful conversations with their doctors.

“As physicians, we are always trying to find ways to offer patients health information that is meaningful to them for individualized care,” said Sumbul Desai, MD, Apple’s vice president of Health. “Seeing medical research reflect what we’re hearing from consumers is positive and we’re excited to see Apple Watch helping even more consumers in the future while collaborating with the medical community to further research.” 


Article Sourcehttps://www.apple.com/newsroom/2019/03/stanford-medicine-announces-results-of-unprecedented-apple-heart-study/

NEWS​

Related News

GrowFL Recognizes Protean BioDiagnostics, Innovator in Precision Oncology, Among Florida’s Top Companies

13 Mar 2025
The GrowFL Florida Companies to Watch awards spotlight high-growth, second-stage businesses driving Florida’s economy.

Open Market Consultation for the search, incorporation and co-creation of new digital technologies based on digital twins for a personalized approach of congenital and complex pathologies

12 Mar 2025
Check out this Open Market Consultation for the search, incorporation and co-creation of new digital technologies based on digital twins for a persona...

Smart Algorithms vs. Breast Cancer: 14 Teams to Develop AI Solutions for Enhancing Breast Cancer Diagnostics in AI4Health.Cro Challenge

12 Mar 2025
In the news piece, readers will learn about the AI4Health.Cro innovation competition that has attracted 14 talented teams to develop AI tools for impr...
Featured

Inside The Digital Health & Wellness Summit 2025 at MWC-4YFN: How ECHAlliance members made an impact

11 Mar 2025
Andy Bleaden shares key takeaways from DHWS25 at 4YFN, where ECHAlliance brought members together, showcased ecosystem innovations, and turned convers...
Featured

ECHAlliance Partners with HealthAI to Advance Responsible AI in Healthcare

11 Mar 2025
ECHAlliance partners with HealthAI - The Global Agency for Responsible AI in Health - to strengthen global AI regulation, offering its members opportu...

Schiltron.io: tech-enabled hardware provider to meet the needs of different health and care environments

10 Mar 2025
Schiltron.io offers a versatile and intelligent portfolio of products and services with a range of smart accessories to meet the needs of different he...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *